Skip to main content
Premium Trial:

Request an Annual Quote

Cellumen Partners with Alzheimer's Foundation on Disease Modeling Systems

NEW YORK (GenomeWeb News) – Cellumen will partner with the Alzheimer’s Drug Discovery Foundation to develop a cellular model that could be used in Alzheimer’s treatments, the company said today.
 
Pittsburgh-based Cellumen plans to use its Cellular Systems Biology technology to develop a panel of assays and biosensors of protein interactions in order to find targets and pathways involved in the disease. This technology could allow researchers to conduct more clinically relevant drug screening, the company believes.
 
“We have the opportunity to revolutionize the treatment of this complex disease by providing pharmaceutical companies with the necessary tools to identify novel chemical modulators of the AD systems biology,” Cellumen CEO Lansing Taylor said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.